की कीमत क्या है Metagenomi, Inc. Common Stock (MGX)

का मूल्य Metagenomi, Inc. Common Stock (MGX) है $1.21

का बाजार पूंजीकरण क्या है Metagenomi, Inc. Common Stock (MGX)

का बाजार पूंजीकरण Metagenomi, Inc. Common Stock (MGX) है $45.55M

Metagenomi, Inc. Common Stock (MGX) P/B अनुपात

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.

वर्ष	P/B अनुपात	परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

वर्ष

P/B अनुपात

परिवर्तन

प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।

कंपनी	P/B अनुपात	P/B अनुपात में अंतर	देश
Vertex Pharmaceuticals Incorporated VRTX.US	6.3419	-	US
Argenx SE ARGX.US	6.2413	-	NL
CSL Limited CSL.AX	2.5054	-	AU
Lonza Group AG LONN.SW	-	-	CH
Moderna, Inc. MRNA.US	3.7087	-	US

कंपनी

P/B अनुपात

P/B अनुपात में अंतर

देश